# Invesco DB Agriculture Fund: financial statements, quarterly

DBA · NYSE · CIK 1383082 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dba.md) · [Financials](/companies/dba/financials.md) · [Filings](/companies/dba/filings.md) · [Insiders](/companies/dba/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dba/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [9.3](/filings/0000950170-24-122588.md) | [9.1 d](/filings/0001193125-26-083545.md) | [7.9](/filings/0000950170-25-067168.md) | [8.5](/filings/0000950170-25-105189.md) | [7.6](/filings/0001193125-25-270326.md) | [7.5 d](/filings/0001193125-26-083545.md) | [6.8](/filings/0001193125-26-209736.md) | [7.0](/filings/0001193125-26-338709.md) | [6.6](/filings/0001193125-25-270326.md) | [6.0 d](/filings/0001193125-26-083545.md) | [5.4](/filings/0001193125-26-209736.md) | [8.7](/filings/0001193125-26-338709.md) |
| Interest expense | $m | [0.0](/filings/0000950170-24-122588.md) | [0.0 d](/filings/0000950170-24-019060.md) | [0.0](/filings/0000950170-24-054963.md) | [0.1](/filings/0000950170-24-092124.md) | [0.1](/filings/0000950170-24-122588.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [13.2](/filings/0000950170-24-122588.md) | [10.6 d](/filings/0001193125-26-083545.md) | [129](/filings/0000950170-25-067168.md) | [(26.5)](/filings/0000950170-25-105189.md) | [59.8](/filings/0001193125-25-270326.md) | [48.2 d](/filings/0001193125-26-083545.md) | [(11.3)](/filings/0001193125-26-209736.md) | [(5.2)](/filings/0001193125-26-338709.md) | [16.9](/filings/0001193125-25-270326.md) | [(10.3) d](/filings/0001193125-26-083545.md) | [55.7](/filings/0001193125-26-209736.md) | [(35.5)](/filings/0001193125-26-338709.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [4.7](/filings/0000950170-25-027262.md) | not reported | not reported | not reported | [13.5](/filings/0001193125-26-083545.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [834](/filings/0000950170-23-060441.md) | [719](/filings/0000950170-25-027262.md) | [789](/filings/0000950170-24-054963.md) | [710](/filings/0000950170-24-092124.md) | [752](/filings/0000950170-24-122588.md) | [788](/filings/0001193125-26-083545.md) | [819](/filings/0000950170-25-067168.md) | [790](/filings/0000950170-25-105189.md) | [792](/filings/0001193125-25-270326.md) | [726](/filings/0001193125-26-338709.md) | [1,218](/filings/0001193125-26-209736.md) | [1,198](/filings/0001193125-26-338709.md) |
| Total liabilities | $m | [19.3](/filings/0000950170-23-060441.md) | [14.7](/filings/0000950170-25-027262.md) | [0.5](/filings/0000950170-24-054963.md) | [0.5](/filings/0000950170-24-092124.md) | [13.8](/filings/0000950170-24-122588.md) | [0.5](/filings/0001193125-26-083545.md) | [0.6](/filings/0000950170-25-067168.md) | [1.1](/filings/0000950170-25-105189.md) | [0.5](/filings/0001193125-25-270326.md) | [3.0](/filings/0001193125-26-338709.md) | [0.6](/filings/0001193125-26-209736.md) | [44.8](/filings/0001193125-26-338709.md) |
| Shareholders' equity | $m | [815](/filings/0000950170-24-122588.md) | [704](/filings/0001193125-26-083545.md) | [789](/filings/0000950170-25-105189.md) | [709](/filings/0001193125-25-270326.md) | [739](/filings/0001193125-25-270326.md) | [787](/filings/0001193125-26-338709.md) | [819](/filings/0001193125-26-338709.md) | [789](/filings/0001193125-26-338709.md) | [792](/filings/0001193125-25-270326.md) | [723](/filings/0001193125-26-338709.md) | [1,217](/filings/0001193125-26-338709.md) | [1,153](/filings/0001193125-26-338709.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [33.5 d](/filings/0000950170-24-122588.md) | [129 d](/filings/0001193125-26-083545.md) | [41.2](/filings/0000950170-25-067168.md) | [53.0 d](/filings/0000950170-25-105189.md) | [30.4 d](/filings/0001193125-25-270326.md) | [12.8 d](/filings/0001193125-26-083545.md) | [(56.3)](/filings/0001193125-26-209736.md) | [25.1 d](/filings/0001193125-26-338709.md) | [13.7 d](/filings/0001193125-25-270326.md) | [56.2 d](/filings/0001193125-26-083545.md) | [(436)](/filings/0001193125-26-209736.md) | [23.0 d](/filings/0001193125-26-338709.md) |
| Dividends paid | $m | not reported | not reported | [0.3](/filings/0000950170-25-067168.md) | [0.0 d](/filings/0000950170-25-105189.md) | [0.0 d](/filings/0001193125-25-270326.md) | [31.8 d](/filings/0001193125-26-083545.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [50.8 d](/filings/0000950170-24-122588.md) | [128 d](/filings/0001193125-26-083545.md) | [58.5](/filings/0000950170-25-067168.md) | [126 d](/filings/0000950170-25-105189.md) | [40.6 d](/filings/0001193125-25-270326.md) | [19.8 d](/filings/0001193125-26-083545.md) | [54.2](/filings/0001193125-26-209736.md) | [75.1 d](/filings/0001193125-26-338709.md) | [34.1 d](/filings/0001193125-25-270326.md) | [39.5 d](/filings/0001193125-26-083545.md) | [44.8](/filings/0001193125-26-209736.md) | [466 d](/filings/0001193125-26-338709.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 43,200,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338709.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.